Biobanking Clinical Trials Genetics In-Vivo 
Drug Discovery World
MARCH 20, 2024
Around 30% of drugs show adverse reactions during human clinical trials despite promising pre-clinical studies. Their adaptability for genetic modifications further positions them as an optimal tool for exploring the mechanisms of action of toxic compounds.
Roots Analysis
SEPTEMBER 18, 2023
While some biobanks ( especially non-clinical ones ) use mechanical freezers for storage, liquid nitrogen is one of the most reliable cryostorage mediums. million people donate blood annually and on a daily basis, approximately 29,000 units of red blood cells are required.
Expert insights. Personalized for you.
59 
Let's personalize your content